Paper39249508
Clinicopathological characteristics of neural epidermal growth factor-like 1 protein-associated membranous glomerulonephritis.
Hyodo T and 6 others. Virchows Arch, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Clinicopathological characteristics of neural epidermal growth factor-like 1 protein-associated membranous glomerulonephritis. Papers, record 39249508. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39249508
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinicopathological characteristics of neural epidermal growth factor-like 1 protein-associated membranous glomerulonephritis.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glomerulonephritis, Membranous | Major topic |
| Nerve Tissue Proteins | Major topic |
| Calcium-Binding Proteins | Major topic |
| Humans | |
| Male | |
| Female | |
| Middle Aged | |
| Aged | |
| Adult | |
| Japan | |
| Immunohistochemistry | |
| Receptors, Phospholipase A2 |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31318463 | Histological grading in primary membranous nephropathy is essential for clinical management and predicts outcome of patients. | Histopathology | 2019 | https://conductscience.org/library/papers/31318463 | PubMed |
| 2 | 37069980 | Neural Epidermal Growth Factor-Like 1-Positive Membranous Nephropathy With Rheumatoid Arthritis. | Kidney Int Rep | 2023 | https://conductscience.org/library/papers/37069980 | PubMed |
| 3 | 34307995 | NELL1-Associated Membranous Glomerulopathy After Hematopoietic Stem Cell Transplantation. | Kidney Int Rep | 2021 | https://conductscience.org/library/papers/34307995 | PubMed |
| 4 | 36096266 | Traditional indigenous medicines are an etiologic consideration for NELL1-positive membranous nephropathy. | Kidney Int | 2022 | https://conductscience.org/library/papers/36096266 | PubMed |
| 5 | 15086481 | Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. | Kidney Int | 2004 | https://conductscience.org/library/papers/15086481 | PubMed |
| 6 | 26847174 | THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity. | Mod Pathol | 2016 | https://conductscience.org/library/papers/26847174 | PubMed |
| 7 | 23223223 | Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. | Nephrol Dial Transplant | 2013 | https://conductscience.org/library/papers/23223223 | PubMed |
| 8 | 28801527 | Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy. | Clin J Am Soc Nephrol | 2017 | https://conductscience.org/library/papers/28801527 | PubMed |
| 9 | 38250076 | Clinicopathological and prognostic characteristics of idiopathic membranous nephropathy with dual antigen positivity. | Front Immunol | 2023 | https://conductscience.org/library/papers/38250076 | PubMed |
| 10 | 34556256 | KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. | Kidney Int | 2021 | https://conductscience.org/library/papers/34556256 | PubMed |
| 11 | 31901340 | Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. | Kidney Int | 2020 | https://conductscience.org/library/papers/31901340 | PubMed |
| 12 | 30868298 | Clinicopathological characteristics of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy. | Virchows Arch | 2019 | https://conductscience.org/library/papers/30868298 | PubMed |
| 13 | 28674044 | PLA2R and THSD7A: Disparate Paths to the Same Disease? | J Am Soc Nephrol | 2017 | https://conductscience.org/library/papers/28674044 | PubMed |
| 14 | 25820371 | Reappraisal of PLA2R1 in membranous nephropathy: immunostaining method influence and association with IgG4-dominant phenotype. | Virchows Arch | 2015 | https://conductscience.org/library/papers/25820371 | PubMed |
| 15 | 25018932 | Chapter 7: Idiopathic membranous nephropathy. | Kidney Int Suppl (2011) | 2012 | https://conductscience.org/library/papers/25018932 | PubMed |
| 16 | 25394321 | Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. | N Engl J Med | 2014 | https://conductscience.org/library/papers/25394321 | PubMed |
| 17 | 19571279 | M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19571279 | PubMed |
| 18 | 35194125 | Prevalence of neural epidermal growth factor-like 1- and exostosin 1/exostosin 2-associated membranous nephropathy: a single-center retrospective study in Japan. | Sci Rep | 2022 | https://conductscience.org/library/papers/35194125 | PubMed |
| 19 | 21566055 | Anti-phospholipase A2 receptor antibody in membranous nephropathy. | J Am Soc Nephrol | 2011 | https://conductscience.org/library/papers/21566055 | PubMed |
| 20 | 37804268 | Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification. | Mayo Clin Proc | 2023 | https://conductscience.org/library/papers/37804268 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42847324 | Distinct Complement Activation Profiles Between NELL1- and PLA2R-Associated Membranous Nephropathy: A Clinicopathological and Proteomic Study. | Nephrology (Carlton) | 2026 | https://conductscience.org/library/papers/42847324 | PubMed |
| 42812913 | Immunotherapy of membranous nephropathy: strategic evolution from CD20 monoclonal antibodies to future vaccines. | Front Immunol | 2026 | https://conductscience.org/library/papers/42812913 | PubMed |
| 42318536 | A Clinicopathologic Study of Neural Epidermal Growth Factor-Like 1-Associated Membranous Nephropathy in a Chinese Cohort. | Kidney Int Rep | 2026 | https://conductscience.org/library/papers/42318536 | PubMed |
| 41579307 | A case of bucillamine-induced membranous nephropathy presenting with acute kidney injury and requiring hemodialysis. | CEN Case Rep | 2026 | https://conductscience.org/library/papers/41579307 | PubMed |
| 40691733 | Antigens in membranous nephropathy: discovery and clinical implications. | Nat Rev Nephrol | 2025 | https://conductscience.org/library/papers/40691733 | PubMed |
| 40553369 | NELL-1-positive membranous nephropathy following gastric cancer in an older living kidney donor: a case report. | CEN Case Rep | 2025 | https://conductscience.org/library/papers/40553369 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| NELL1 | 4745 | PubTator's text mining | https://conductscience.org/library/genes/4745 | NCBI Gene |
| PLA2R1 | 22925 | PubTator's text mining | https://conductscience.org/library/genes/22925 | NCBI Gene |
| THSD7A | 221981 | PubTator's text mining | https://conductscience.org/library/genes/221981 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39249508
GET https://conductscience.org/api/papers/v1/39249508/references?page=2